MARKET

SPRO

SPRO

Spero Therapeuti
NASDAQ
2.330
-0.040
-1.69%
After Hours: 2.389 +0.059 +2.52% 18:02 03/27 EDT
OPEN
2.300
PREV CLOSE
2.370
HIGH
2.440
LOW
2.280
VOLUME
498.71K
TURNOVER
--
52 WEEK HIGH
3.220
52 WEEK LOW
0.5052
MARKET CAP
131.27M
P/E (TTM)
-2.9312
1D
5D
1M
3M
1Y
5Y
1D
Spero Therapeutics (SPRO) Earnings Turn Positive Challenging Bearish Profitability Narratives
Simply Wall St · 16h ago
Spero Therapeutics Q4 revenue nearly triples, swings to profit
Reuters · 1d ago
CORRECTED-Spero Therapeutics Q4 revenue nearly triples, swings to profit
Reuters · 1d ago
Spero Therapeutics Non-GAAP EPS of $0.53, revenue of $41.3M
Seeking Alpha · 1d ago
Spero Therapeutics FY2025 net income swings to $8.6 million; revenue rises 39.2% to $66.8 million
Reuters · 1d ago
Spero Therapeutics Q4 EPS $0.53 Beats $(0.40) Estimate, Sales $41.297M Up From $15.044M YoY
Benzinga · 1d ago
Press Release: Spero Therapeutics Announces Fourth Quarter and Full Year 2025 Operating Results and Provides a Business Update
Dow Jones · 1d ago
*Spero Therapeutics 4Q Net $31.5M >SPRO
Dow Jones · 1d ago
More
About SPRO
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying and developing novel treatments for rare diseases and diseases caused by multi-drug resistant (MDR) bacterial infections with unmet need. Its product candidate SPR720 is an investigational, chemically stable phosphate ester prodrug that is converted in vivo to SPR719 for the treatment of nontuberculous mycobacterial (NTM) pulmonary disease. Its clinical stage product candidate, tebipenem HBr is an investigational oral carbapenem antibiotic being developed for the treatment of complicated urinary tract infections (cUTIs) including acute pyelonephritis (AP) to help patients potentially reduce duration of in-patient therapy.

Webull offers Spero Therapeutics Inc stock information, including NASDAQ: SPRO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPRO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SPRO stock methods without spending real money on the virtual paper trading platform.